Whistleblower Charges Drug Company With Deceptive Practices

dc.creator	Lenzer, Jeanne	en
dc.date.accessioned	2016-01-09T00:10:41Z	en
dc.date.available	2016-01-09T00:10:41Z	en
dc.date.created	2003-03-22	en
dc.date.issued	2003-03-22	en
dc.identifier	doi:10.1136/bmj.326.7390.620	en
dc.identifier.bibliographicCitation	BMJ: British Medical Journal 2003 March 22; 326(7390): 620	en
dc.identifier.uri	http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Whistleblower+charges+drug+company+with+deceptive+practices&title=BMJ:+British+Medical+Journal+&volume=326&issue=7390&spage=620&date=2003-03&au=Lenzer,+Jeanne	en
dc.identifier.uri	http://dx.doi.org/10.1136/bmj.326.7390.620	en
dc.identifier.uri	http://hdl.handle.net/10822/1001404	en
dc.format	News Article	en
dc.language	en	en
dc.source	eweb:258685	en
dc.subject.classification	Drugs and Drug Industry	en
dc.subject.classification	Business Ethics	en
dc.title	Whistleblower Charges Drug Company With Deceptive Practices	en
dc.provenance	Citation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.	en
dc.provenance	Citation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.	en

Related items